BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17686346)

  • 1. Treating fatigue.
    Lapierre Y; Hum S
    Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating fatigue in patients with MS: one step forward, one step back.
    Schwid SR; Murray TJ
    Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
    Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
    Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of fatigue in patients with multiple sclerosis.
    Zifko UA
    Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in multiple sclerosis.
    Krupp LB; Christodoulou C
    Curr Neurol Neurosci Rep; 2001 May; 1(3):294-8. PubMed ID: 11898532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatments for fatigue associated with palliative care.
    Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatments for fatigue associated with palliative care.
    Kirshbaum M
    Clin J Oncol Nurs; 2011 Aug; 15(4):438-9. PubMed ID: 21810580
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatigue associated with multiple sclerosis: diagnosis, impact and management.
    Bakshi R
    Mult Scler; 2003 Jun; 9(3):219-27. PubMed ID: 12814166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management options in multiple sclerosis-associated fatigue.
    Amato MP; Portaccio E
    Expert Opin Pharmacother; 2012 Feb; 13(2):207-16. PubMed ID: 22220738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue in MS.
    Dulli D; Schutta H
    Neurology; 1996 Nov; 47(5):1351. PubMed ID: 8909465
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatigue in multiple sclerosis - a brief review.
    Induruwa I; Constantinescu CS; Gran B
    J Neurol Sci; 2012 Dec; 323(1-2):9-15. PubMed ID: 22935407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine for fatigue in multiple sclerosis.
    Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ['Fatigue' in multiple sclerosis].
    Zimmermann C; Hohlfeld R
    Nervenarzt; 1999 Jun; 70(6):566-74. PubMed ID: 10412704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis-related fatigue.
    MacAllister WS; Krupp LB
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):483-502. PubMed ID: 15893683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in multiple sclerosis: an overview of assessment and pharmacologic treatment.
    Dunmore FR
    Adv NPs PAs; 2013 Apr; 4(4):23-5, 32. PubMed ID: 23599993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathophysiology and treatment of fatigue in multiple sclerosis].
    Boërio D; Lefaucheur JP; Hogrel JY; Créange A
    Rev Neurol (Paris); 2006 Mar; 162(3):311-20. PubMed ID: 16585886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.